Literature DB >> 26004343

Three-dimensional (3D) culture of bone-derived human 786-O renal cell carcinoma retains relevant clinical characteristics of bone metastases.

Tianhong Pan1, Eliza L S Fong2, Mariane Martinez3, Daniel A Harrington3, Sue-Hwa Lin4, Mary C Farach-Carson5, Robert L Satcher6.   

Abstract

Bone metastases from renal cell carcinoma (RCC) are typically lytic, destructive, and resistant to treatment regimens. Current in vitro models for studying metastasis introduce artifacts that limit their usefulness. Many features of tumors growing in bone are lost when human RCC cells are cultured in two-dimensional (2D) plastic substrata. In this study, we established that RCC spheroids, consisting of aggregates of cells, can be grown in a three-dimensional (3D) hyaluronate hydrogel-based culture system. The bone-derived human 786-O RCC subline proliferated and survived long term in these hydrogels. Additionally, RCC spheroids in 3D hydrogels demonstrated lower proliferation rates than their counterparts grown in 2D. Overall, gene expression patterns of RCC spheroids in 3D more closely mimicked those observed in vivo than did those of cells grown in 2D. Of particular importance, selected adhesion molecules, angiogenesis factors, and osteolytic factors that have been shown to be involved in RCC bone metastasis were found to be expressed at higher levels in 3D than in 2D cultures. We propose that the 3D culture system provides an improved platform for RCC bone metastasis studies compared with 2D systems.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Bone metastasis; Hyaluronic acid; Hydrogel; Renal cell carcinoma; Three dimensional culture

Mesh:

Substances:

Year:  2015        PMID: 26004343      PMCID: PMC4530612          DOI: 10.1016/j.canlet.2015.05.019

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  49 in total

1.  Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas.

Authors:  M S Wiesener; P M Münchenhagen; I Berger; N V Morgan; J Roigas; A Schwiertz; J S Jürgensen; G Gruber; P H Maxwell; S A Löning; U Frei; E R Maher; H J Gröne; K U Eckardt
Journal:  Cancer Res       Date:  2001-07-01       Impact factor: 12.701

2.  Cadherin-11 increases migration and invasion of prostate cancer cells and enhances their interaction with osteoblasts.

Authors:  Chih-Fen Huang; Cristina Lira; Khoi Chu; Mehmet Asim Bilen; Yu-Chen Lee; Xiangcang Ye; Soo Mi Kim; Angelica Ortiz; Fe-Lin Lin Wu; Christopher J Logothetis; Li-Yuan Yu-Lee; Sue-Hwa Lin
Journal:  Cancer Res       Date:  2010-05-18       Impact factor: 12.701

Review 3.  Hydrogels for in vivo-like three-dimensional cellular studies.

Authors:  Ross DeVolder; Hyun-Joon Kong
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2012-05-21

4.  Unique angiogenic and vasculogenic properties of renal cell carcinoma in a xenograft model of bone metastasis are associated with high levels of vegf-a and decreased ang-1 expression.

Authors:  Chao Xie; Edward M Schwarz; Erik R Sampson; Robinder S Dhillon; Dan Li; Regis J O'Keefe; Wakenda Tyler
Journal:  J Orthop Res       Date:  2011-08-01       Impact factor: 3.494

Review 5.  RANKL-RANK signaling in osteoclastogenesis and bone disease.

Authors:  Teiji Wada; Tomoki Nakashima; Nishina Hiroshi; Josef M Penninger
Journal:  Trends Mol Med       Date:  2005-12-13       Impact factor: 11.951

6.  Skeletal complications and survival in renal cancer patients with bone metastases.

Authors:  Emma Woodward; Satinder Jagdev; Lucy McParland; Katy Clark; Walter Gregory; Alex Newsham; Suzanne Rogerson; Kate Hayward; Peter Selby; Janet Brown
Journal:  Bone       Date:  2010-09-18       Impact factor: 4.398

7.  Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model.

Authors:  B A Foster; J R Gingrich; E D Kwon; C Madias; N M Greenberg
Journal:  Cancer Res       Date:  1997-08-15       Impact factor: 12.701

8.  Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo.

Authors:  J de la Mata; H L Uy; T A Guise; B Story; B F Boyce; G R Mundy; G D Roodman
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

9.  Hyaluronan (HA) interacting proteins RHAMM and hyaluronidase impact prostate cancer cell behavior and invadopodia formation in 3D HA-based hydrogels.

Authors:  Lisa A Gurski; Xian Xu; Lyana N Labrada; Ngoc T Nguyen; Longxi Xiao; Kenneth L van Golen; Xinqiao Jia; Mary C Farach-Carson
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

10.  Cadherin-11 in renal cell carcinoma bone metastasis.

Authors:  Robert L Satcher; Tianhong Pan; Chien-Jui Cheng; Yu-Chen Lee; Song-Chang Lin; Guoyu Yu; Xiaoxia Li; Anh G Hoang; Pheroze Tamboli; Eric Jonasch; Gary E Gallick; Sue-Hwa Lin
Journal:  PLoS One       Date:  2014-02-24       Impact factor: 3.240

View more
  16 in total

Review 1.  Heralding a new paradigm in 3D tumor modeling.

Authors:  Eliza L S Fong; Daniel A Harrington; Mary C Farach-Carson; Hanry Yu
Journal:  Biomaterials       Date:  2016-09-02       Impact factor: 12.479

2.  Development of a 3D bone marrow adipose tissue model.

Authors:  Heather Fairfield; Carolyne Falank; Mariah Farrell; Calvin Vary; Joshua M Boucher; Heather Driscoll; Lucy Liaw; Clifford J Rosen; Michaela R Reagan
Journal:  Bone       Date:  2018-01-31       Impact factor: 4.398

3.  Tissue-engineered 3D cancer-in-bone modeling: silk and PUR protocols.

Authors:  Ushashi Dadwal; Carolyne Falank; Heather Fairfield; Sarah Linehan; Clifford J Rosen; David L Kaplan; Julie Sterling; Michaela R Reagan
Journal:  Bonekey Rep       Date:  2016-10-19

Review 4.  Evolving cancer-niche interactions and therapeutic targets during bone metastasis.

Authors:  Robert L Satcher; Xiang H-F Zhang
Journal:  Nat Rev Cancer       Date:  2021-10-05       Impact factor: 69.800

5.  3d Tissue Engineered In Vitro Models Of Cancer In Bone.

Authors:  Anna M Sitarski; Heather Fairfield; Carolyne Falank; Michaela R Reagan
Journal:  ACS Biomater Sci Eng       Date:  2017-06-09

Review 6.  Personalized in vitro cancer models to predict therapeutic response: Challenges and a framework for improvement.

Authors:  Molly M Morgan; Brian P Johnson; Megan K Livingston; Linda A Schuler; Elaine T Alarid; Kyung E Sung; David J Beebe
Journal:  Pharmacol Ther       Date:  2016-05-21       Impact factor: 12.310

7.  3D models of the bone marrow in health and disease: yesterday, today and tomorrow.

Authors:  Annamarija Raic; Toufik Naolou; Anna Mohra; Chandralekha Chatterjee; Cornelia Lee-Thedieck
Journal:  MRS Commun       Date:  2018-09-25       Impact factor: 2.566

Review 8.  Choosing the right cell line for renal cell cancer research.

Authors:  Klaudia K Brodaczewska; Cezary Szczylik; Michal Fiedorowicz; Camillo Porta; Anna M Czarnecka
Journal:  Mol Cancer       Date:  2016-12-19       Impact factor: 27.401

9.  Cabozantinib Reverses Renal Cell Carcinoma-mediated Osteoblast Inhibition in Three-dimensional Coculture In Vitro and Reduces Bone Osteolysis In Vivo.

Authors:  Tianhong Pan; Mariane Martinez; Kelsea M Hubka; Jian H Song; Song-Chang Lin; Guoyu Yu; Yu-Chen Lee; Gary E Gallick; Shi-Ming Tu; Daniel A Harrington; Mary C Farach-Carson; Sue-Hwa Lin; Robert L Satcher
Journal:  Mol Cancer Ther       Date:  2020-03-27       Impact factor: 6.009

Review 10.  A systematic review on in vitro 3D bone metastases models: A new horizon to recapitulate the native clinical scenario?

Authors:  Francesca Salamanna; Deyanira Contartese; Melania Maglio; Milena Fini
Journal:  Oncotarget       Date:  2016-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.